Swedish and Nordic Lung Cancer Insights – October Update
This overview summarizes recent Swedish and Nordic research in lung cancer. The Swedish studies examine treatment costs, familial and genetic risk factors, lung cancer risk in interstitial lung disease, and biomarker-based treatment response, as well as a national phase III trial in EGFR-mutated disease. Nordic collaborative studies compare epidemiology, care pathways, and survival across Denmark, Finland, Norway, and Sweden, providing insights into regional differences and areas for improvement in lung cancer care.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in
